Details for New Drug Application (NDA): 209446
The generic ingredient in MIRABEGRON is mirabegron. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the mirabegron profile page.
Summary for 209446
| Tradename: | MIRABEGRON |
| Applicant: | Sawai Usa |
| Ingredient: | mirabegron |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 25MG | ||||
| Approval Date: | Dec 27, 2019 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
